Ubs Group Ag Neuro Sense Therapeutics Ltd. Call Options Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
16Shares Held
443KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il149KShares$176,1060.0% of portfolio
-
Morgan Stanley New York, NY79.9KShares$94,2820.0% of portfolio
-
Squarepoint Ops LLC New York, NY49.9KShares$58,9110.0% of portfolio
-
Meitav Dash Investments LTD40KShares$47,2000.0% of portfolio
-
Jane Street Group, LLC New York, NY28.7KShares$33,8530.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $13.8M